Goldman Sachs Upgrades Fulcrum Therapeutics (FULC) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Goldman Sachs Upgrades Fulcrum Therapeutics (FULC) to Buy
(NASDAQ: FULC) Delayed: 3.77 +0.07 (1.89%)
Previous Close $3.70    52 Week High $ 
Open $3.69    52 Week Low $ 
Day High $3.89    P/E N/A 
Day Low $3.63    EPS $ 
Volume 2,868,623